small cell lung cancer: interpreting data from impower133
Published 5 years ago • 189 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer
-
7:20
small-cell lung cancer: the impower133 and caspian trials
-
6:33
a win for small–cell lung cancer: impower 133
-
5:06
impower133 in sclc
-
8:11
first-line immunotherapy: impower133 regimen
-
6:23
adaura trial; early stage non–small cell lung cancer
-
3:36
highlights from wclc 2018: nelson, alta, impower133 & pacific
-
5:23
atezolizumab carboplatin/etoposide for extensive-stage small cell lung cancer: impower133 update
-
6:32
the caspian versus impower133 regimen
-
3:00
small-cell lung cancer: future directions in care
-
1:39
frontline i-o strategies in sclc: practical implications
-
1:50
impower133: atezolizumab, carboplatin plus etoposide for sclc
-
4:38
molecular testing’s role in non–small cell lung cancer
-
5:22
chemoimmunotherapy for es sclc: impower133 trial
-
7:34
pd-l1 as a biomarker in squamous non-small cell lung cancer
-
0:48
immunotherapy for patients with small-cell lung cancer
-
2:54
current frontline management of small cell lung cancer
-
4:52
targeting the immune system in non-small cell lung cancer
-
7:13
i/o chemotherapy in treatment-naïve es-sclc